Varaico: Literature-Extracted Genetic Variants

Gene:RAG2
Variant:p.G35V
Back to variants list

RAG2

NM_000536.4:p.G35V

Associated Papers

Double-hit RAG2 mutation presenting with hyper-immunoglobulin E and preserved T cells diagnostic challenge: a case report.

Hasan FM et al.

Journal of Medical Case Reports, 2025

Exome sequencing reveals new insights into the germline landscape of inflammatory breast cancer among Tunisian patients.

Boujemaa M et al.

Journal of Translational Medicine, 2025

41088366 (PubMed )
Supplement: 12967_2025_7027_MOESM1_ESM.xlsx › S5

RAG genomic variation causes autoimmune diseases through specific structure-based mechanisms of enzyme dysregulation.

Haque N et al.

Iscience, 2023

37854700 (PubMed )
Supplement: mmc3.xlsx › Table_S2_RAG2_Scores_57_74

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.

Iancu O et al.

Molecular Therapy. Nucleic Acids, 2023

Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells.

Csomos K et al.

Nature Immunology, 2022

35902638 (PubMed )
Supplement: 41590_2022_1271_MOESM1_ESM.xlsx › Table_2

Genetic Testing in Egyptian Patients with Inborn Errors of Immunity: a Single-Center Experience.

El Hawary RE et al.

Journal of Clinical Immunology, 2022

Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.

Chan KW et al.

Frontiers in Immunology, 2022

35874699 (PubMed )
Supplement: Table_2.xlsx › Suppl_table_2

RAG2 abolishes RAG1 aggregation to facilitate V(D)J recombination.

Gan T et al.

Cell Reports, 2021

Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.

Lugo-Reyes SO et al.

Journal of Clinical Immunology, 2021

Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.

Stranneheim H et al.

Genome Medicine, 2021

33726816 (PubMed )
Supplement: 13073_2021_855_MOESM3_ESM.xlsx › Reported_genes_and_variants

Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Morris EC

Hematology. American Society of Hematology. Education Program, 2020

A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.

Greenberg-Kushnir N et al.

Journal of Clinical Immunology, 2020

Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.

Manor U et al.

Immunologic Research, 2019

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype.

Tirosh I et al.

The Journal of Allergy and Clinical Immunology, 2019

Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.

Meshaal SS et al.

Clinical and Experimental Immunology, 2019

Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.

Aluri J et al.

Frontiers in Immunology, 2019

Co-appearance of OPV and BCG vaccine-derived complications in two infants with severe combined immunodeficiency.

Heiman S et al.

Immunologic Research, 2018

Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined Immunodeficiency.

Luk ADW et al.

Frontiers in Immunology, 2017

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.

Dobbs K et al.

Frontiers in Immunology, 2017

Human RAG mutations: biochemistry and clinical implications.

Notarangelo LD et al.

Nature Reviews. Immunology, 2016

The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.

Lev A et al.

Plos One, 2012

Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes.

Lev A et al.

Clinical & Developmental Immunology, 2012

Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or Omenn syndrome.

Dalal I et al.

Clinical Immunology (orlando, Fla.), 2011

RAG-dependent primary immunodeficiencies.

Sobacchi C et al.

Human Mutation, 2006

Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation.

Hönig M et al.

Current Opinion in Rheumatology, 2006

Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.

Dalal I et al.

Clinical Immunology (orlando, Fla.), 2005

Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.

Tabori U et al.

Clinical Genetics, 2004

Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.

Corneo B et al.

The Journal of Biological Chemistry, 2000

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."